|
US4088751A
(en)
|
1972-04-07 |
1978-05-09 |
Colgate-Palmolive Company |
Self-heating cosmetic
|
|
US4171429A
(en)
|
1977-03-29 |
1979-10-16 |
Research Corporation |
Pyrimidine to pyrimidine transformation process
|
|
EP0028489B1
(en)
|
1979-11-05 |
1983-10-05 |
Beecham Group Plc |
Enzyme derivatives, and their preparation
|
|
JPS5770693A
(en)
|
1980-10-22 |
1982-05-01 |
Fuji Photo Film Co Ltd |
Desensitizing composition
|
|
WO1989010701A1
(en)
|
1988-05-05 |
1989-11-16 |
Basf Aktiengesellschaft |
Substances based on uracil-derivates for stimulating growth and reducing fat in animals
|
|
KR0155168B1
(ko)
|
1989-09-29 |
1998-11-16 |
미우라 아끼라 |
6-치환된 아시클로피리미딘 뉴클레오시드 유도체 및 이를 활성성분으로 함유하는 항비루스제
|
|
JPH0699170B2
(ja)
|
1990-01-19 |
1994-12-07 |
日東紡績株式会社 |
耐火被覆材
|
|
JPH0525144A
(ja)
|
1991-04-15 |
1993-02-02 |
Nissan Chem Ind Ltd |
ウラシル誘導体及び有害生物防除剤
|
|
JPH0525142A
(ja)
|
1991-07-12 |
1993-02-02 |
Nissan Chem Ind Ltd |
ウラシル誘導体及び有害生物防除剤
|
|
JPH0543555A
(ja)
|
1991-08-13 |
1993-02-23 |
Nissan Chem Ind Ltd |
ウラシル誘導体及び有害生物防除剤
|
|
TW284688B
(ru)
|
1991-11-20 |
1996-09-01 |
Takeda Pharm Industry Co Ltd |
|
|
GB2263639A
(en)
|
1992-01-28 |
1993-08-04 |
Merck & Co Inc |
Substituted pyrimidinones as neurotensin antagonists
|
|
JPH063761A
(ja)
|
1992-06-19 |
1994-01-14 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
|
US6444656B1
(en)
|
1992-12-23 |
2002-09-03 |
Biochem Pharma, Inc. |
Antiviral phosphonate nucleotides
|
|
KR0151811B1
(ko)
|
1993-12-21 |
1998-10-15 |
강박광 |
신규한 항바이러스성 2,4-피리미딘디온 유도체 및 그의 제조방법
|
|
JP3781200B2
(ja)
|
1994-04-27 |
2006-05-31 |
コニカミノルタホールディングス株式会社 |
ハロゲン化銀写真感光材料の処理方法
|
|
JP3261641B2
(ja)
|
1994-04-28 |
2002-03-04 |
コニカ株式会社 |
ハロゲン化銀写真感光材料の処理方法
|
|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
|
WO1996014846A1
(en)
|
1994-11-16 |
1996-05-23 |
Synaptic Pharmaceutical Corporation |
Dihydropyrimidines and uses thereof
|
|
US6268369B1
(en)
|
1994-11-16 |
2001-07-31 |
Synaptic Pharmaceutical Corporation |
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
|
|
US6228861B1
(en)
|
1995-11-16 |
2001-05-08 |
Synaptic Pharmaceutical Corporation |
Dihydropyrimidines and uses thereof
|
|
WO1997017969A1
(en)
|
1995-11-16 |
1997-05-22 |
Synaptic Pharmaceutical Corporation |
Dihydropyrimidines and uses thereof
|
|
US5719190A
(en)
|
1996-02-28 |
1998-02-17 |
Pfizer Inc. |
Inhibition of myeloperoxidase activity
|
|
US6245773B1
(en)
|
1996-05-16 |
2001-06-12 |
Synaptic Pharmaceutical Corporation |
5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
|
|
JP2000506904A
(ja)
|
1996-05-16 |
2000-06-06 |
シナプティック・ファーマスーティカル・コーポレーション |
ジヒドロピリミジン類およびその使用
|
|
US6172066B1
(en)
|
1996-05-16 |
2001-01-09 |
Synaptic Pharmaceutical Corporation |
Dihydropyrimidines and uses thereof
|
|
DE19647380A1
(de)
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
JP2002514195A
(ja)
|
1996-12-05 |
2002-05-14 |
アムジエン・インコーポレーテツド |
置換ピリミジン化合物およびそれの使用
|
|
US6096753A
(en)
|
1996-12-05 |
2000-08-01 |
Amgen Inc. |
Substituted pyrimidinone and pyridone compounds and methods of use
|
|
IL130181A0
(en)
|
1996-12-05 |
2000-06-01 |
Amgen Inc |
Substituted pyrimidone and pyridone compounds and methods of use
|
|
HUP0301101A3
(en)
|
1996-12-31 |
2009-03-30 |
Reddy S Res Foundation |
Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
|
TW536540B
(en)
|
1997-01-30 |
2003-06-11 |
Bristol Myers Squibb Co |
Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
|
|
DE19731784A1
(de)
|
1997-07-24 |
1999-02-04 |
Bayer Ag |
Substituierte N-Aryl-N-thioxocarbonyl-sulfonamide
|
|
US6130340A
(en)
|
1998-01-13 |
2000-10-10 |
President And Fellows Of Harvard College |
Asymmetric cycloaddition reactions
|
|
US6211370B1
(en)
|
1998-01-13 |
2001-04-03 |
Harvard University |
Asymmetric cycloaddition reactions
|
|
WO1999059561A2
(en)
|
1998-05-18 |
1999-11-25 |
Hensley, Kenneth, L. |
Resveratrol inhibition of myeloperoxidase
|
|
CA2336714A1
(en)
|
1998-07-06 |
2000-01-13 |
Bristol-Myers Squibb Company |
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
|
|
CA2252144A1
(en)
|
1998-10-16 |
2000-04-16 |
University Of Alberta |
Dual action anticancer prodrugs
|
|
DE19918725A1
(de)
|
1999-04-24 |
2000-10-26 |
Bayer Ag |
Substituierte N-Cyano-sulfonsäureanilide
|
|
WO2000075136A1
(en)
|
1999-06-02 |
2000-12-14 |
Janssen Pharmaceutica N.V. |
Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
|
|
IT1307786B1
(it)
|
1999-07-22 |
2001-11-19 |
Bracco Spa |
Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
|
|
JP2001131133A
(ja)
|
1999-08-23 |
2001-05-15 |
Sankyo Co Ltd |
新規ミエロペルオキシダーゼ阻害物質およびその製造方法
|
|
MY125533A
(en)
|
1999-12-06 |
2006-08-30 |
Bristol Myers Squibb Co |
Heterocyclic dihydropyrimidine compounds
|
|
GB2362101A
(en)
|
2000-05-12 |
2001-11-14 |
Astrazeneca Ab |
Treatment of chronic obstructive pulmonary disease
|
|
GB0013655D0
(en)
|
2000-06-05 |
2000-07-26 |
Prolifix Ltd |
Therapeutic compounds
|
|
JO2352B1
(en)
|
2000-06-22 |
2006-12-12 |
جانسين فارماسيوتيكا ان. في |
Compounds for the treatment of non-adaptation of the bottom of the uterus
|
|
US6720324B2
(en)
|
2000-07-05 |
2004-04-13 |
Synaptic Pharmaceutical Corporation |
Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
|
|
EP1299362A4
(en)
|
2000-07-05 |
2004-11-03 |
Synaptic Pharma Corp |
SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
|
|
ATE261470T1
(de)
|
2000-07-14 |
2004-03-15 |
Akzo Nobel Nv |
Stabilisatorensystem, das hydroxysäuren enthält
|
|
DE10034800A1
(de)
|
2000-07-18 |
2002-01-31 |
Bayer Ag |
Substituierte Benzostickstoffheterocyclen
|
|
DE10034803A1
(de)
|
2000-07-18 |
2002-01-31 |
Bayer Ag |
Substituierte Sulfonsäureanilide
|
|
KR100799789B1
(ko)
|
2000-07-31 |
2008-01-31 |
브랜데이스 유니버시티 |
키랄 2- 및 3-치환된 카르복실산의 속도론적 분할
|
|
WO2003011799A1
(en)
|
2000-07-31 |
2003-02-13 |
Brandeis University |
Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids
|
|
US6562967B2
(en)
|
2000-07-31 |
2003-05-13 |
Brandeis University |
Kinetic resolutions of chiral 2-and-3-substituted carboxylic acids
|
|
EP2141244A1
(en)
|
2000-10-18 |
2010-01-06 |
Pharmasset, Inc. |
Multiplex quantification of nucleic acids in diseased cells
|
|
KR101005299B1
(ko)
|
2000-10-18 |
2011-01-04 |
파마셋 인코포레이티드 |
바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드
|
|
DE10108995A1
(de)
|
2001-02-23 |
2002-09-05 |
Abbott Gmbh & Co Kg |
Substituierte Pyrimidinon-Derivate als Liganden von Integrinrezeptoren
|
|
WO2002069903A2
(en)
|
2001-03-06 |
2002-09-12 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
|
CA2446039A1
(en)
|
2001-05-08 |
2002-11-14 |
Astrazeneca Ab |
An assay for detecting inhibitors of the enzyme mueloperokidase
|
|
ATE530520T1
(de)
|
2001-08-10 |
2011-11-15 |
Shionogi & Co |
Antivirales mittel
|
|
US7105559B2
(en)
|
2001-10-03 |
2006-09-12 |
Pharmacia Corporation |
Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
|
|
EP1438292A1
(en)
|
2001-10-03 |
2004-07-21 |
Pharmacia Corporation |
6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
|
|
MXPA04003167A
(es)
|
2001-10-03 |
2004-07-08 |
Pharmacia Corp |
Compuestos heterociclicos insaturados de 6 miembros utiles para la inhibicion selectiva de la cascada de coagulacion.
|
|
MXPA04003169A
(es)
|
2001-10-03 |
2004-07-08 |
Pharmacia Corp |
Profarmacos de compuestos policiclicos sustituidos utiles para inhibicion selectiva de la cascada de coagulacion.
|
|
AU2003205536A1
(en)
|
2002-01-11 |
2003-07-24 |
Statens Serum Institut |
Anti-retroviral 5,6-disubstituted acyclopyrimidine nucleoside derivatives
|
|
CN1642599A
(zh)
|
2002-02-27 |
2005-07-20 |
辉瑞产品公司 |
Acc抑制剂
|
|
WO2003084936A2
(en)
|
2002-04-10 |
2003-10-16 |
Orchid Chemicals & Pharmaceuticals Limited |
Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
|
|
AR039385A1
(es)
|
2002-04-19 |
2005-02-16 |
Astrazeneca Ab |
Derivados de tioxantina como inhibidores de la mieloperoxidasa
|
|
ES2572808T3
(es)
|
2002-05-16 |
2016-06-02 |
Merial, Inc. |
Derivados de piridincarboxamida y su utilización como plaguicidas
|
|
EP1394241A1
(en)
|
2002-08-07 |
2004-03-03 |
Rohm And Haas Company |
Cyclic thioureas as additives for lubricating oils
|
|
EP1394242A3
(en)
|
2002-08-07 |
2004-04-21 |
Rohm And Haas Company |
Cyclic thioureas and their use as additives for lubricating oils
|
|
WO2004037159A2
(en)
|
2002-10-23 |
2004-05-06 |
Obetherapy Biotechnology |
Compounds, compositions and methods for modulating fat metabolism
|
|
US20050096319A1
(en)
|
2003-02-21 |
2005-05-05 |
Balzarini Jan M.R. |
Identification of compounds that inhibit replication of human immunodeficiency virus
|
|
EP1603546A1
(en)
|
2003-02-21 |
2005-12-14 |
Tripep AB |
Glycinamide derivative for inhibiting hiv replication
|
|
US7863313B2
(en)
|
2003-04-07 |
2011-01-04 |
Cortical Pty Ltd |
Methods for the treatment of inflammatory diseases
|
|
US7485604B2
(en)
|
2003-05-27 |
2009-02-03 |
Fujifilm Corporation |
Lubricant composition and method for using and preparing thereof
|
|
US7947817B2
(en)
|
2003-06-30 |
2011-05-24 |
Roche Molecular Systems, Inc. |
Synthesis and compositions of 2'-terminator nucleotides
|
|
US7572581B2
(en)
|
2003-06-30 |
2009-08-11 |
Roche Molecular Systems, Inc. |
2′-terminator nucleotide-related methods and systems
|
|
MXPA06006899A
(es)
|
2003-12-22 |
2006-09-04 |
Gilead Sciences Inc |
Derivados de carbovir y abacavir 4'-sustituidos asi como compuestos relacionados con actividad antiviral de virus de inmunodeficiencia humana y virus de la hepatitis c.
|
|
CN102127053A
(zh)
|
2004-03-15 |
2011-07-20 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
|
ATE437870T1
(de)
|
2004-05-12 |
2009-08-15 |
Pfizer Prod Inc |
Prolinderivate und deren verwendung als dipeptidylpeptidase-iv-inhibitoren
|
|
US7745125B2
(en)
|
2004-06-28 |
2010-06-29 |
Roche Molecular Systems, Inc. |
2′-terminator related pyrophosphorolysis activated polymerization
|
|
US7928207B2
(en)
|
2004-06-28 |
2011-04-19 |
Roche Molecular Systems, Inc |
Synthesis and compositions of nucleic acids comprising 2′-terminator nucleotides
|
|
EP1616874A1
(en)
|
2004-07-14 |
2006-01-18 |
Universiteit Gent |
Mono- and bicyclic compounds with therapeutic activity and pharmaceutical compositions including them
|
|
EP1778778A4
(en)
|
2004-08-12 |
2011-04-27 |
King Industries Inc |
METAL-ORGANIC COMPOSITIONS AND COATING COMPOSITIONS
|
|
US7485729B2
(en)
|
2004-08-12 |
2009-02-03 |
King Industries, Inc. |
Organometallic compositions and coating compositions
|
|
US20060100226A1
(en)
|
2004-09-10 |
2006-05-11 |
Sikorski James A |
2-Thiopyrimidinones as therapeutic agents
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
WO2006070292A2
(en)
|
2004-10-12 |
2006-07-06 |
Queen's University At Kingston |
Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
|
|
SE0402591D0
(sv)
|
2004-10-25 |
2004-10-25 |
Astrazeneca Ab |
Novel use
|
|
MY140748A
(en)
|
2004-12-06 |
2010-01-15 |
Astrazeneca Ab |
Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
|
|
US20060194821A1
(en)
|
2005-02-18 |
2006-08-31 |
The Brigham And Women's Hospital, Inc. |
Compounds inhibiting the aggregation of superoxide dismutase-1
|
|
EP1731911A1
(fr)
|
2005-06-07 |
2006-12-13 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Procédé utile pour la détection d'encéphalopathies
|
|
US7399786B2
(en)
|
2005-06-30 |
2008-07-15 |
Bexel Pharmaceuticals, Inc. |
Derivatives of amino acids for treatment of obesity and related disorders
|
|
US8546309B2
(en)
|
2005-07-01 |
2013-10-01 |
Dako Denmark A/S |
Monomeric and polymeric linkers useful for conjugating biological molecules and other substances
|
|
US20100105145A1
(en)
|
2005-07-01 |
2010-04-29 |
Dako Denmark A/S |
Method of simultaneously visualizing multiple biological targets
|
|
WO2007021803A1
(en)
|
2005-08-12 |
2007-02-22 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
NZ568666A
(en)
|
2005-11-30 |
2011-09-30 |
Vertex Pharma |
[1,2,4]Triazolo[3,4-b][1,3,4]thiadiazole derivative as inhibitors of c-Met
|
|
US20090042863A1
(en)
|
2005-12-28 |
2009-02-12 |
Takeda Pharmaceutical Company Limited |
Therapeutic Agent for Diabetes
|
|
DE102006000651A1
(de)
|
2006-01-03 |
2007-07-12 |
Degussa Gmbh |
Präparation aus Ionischen Flüssigkeiten und Harzen
|
|
DE102006000649A1
(de)
|
2006-01-03 |
2007-07-05 |
Degussa Gmbh |
Universell einsetzbare Zusammensetzungen
|
|
JP5025142B2
(ja)
|
2006-02-27 |
2012-09-12 |
株式会社東芝 |
モータ制御装置
|
|
JP5025144B2
(ja)
|
2006-02-28 |
2012-09-12 |
Ｊｘ日鉱日石エネルギー株式会社 |
内燃機関用潤滑油組成物
|
|
UY30267A1
(es)
|
2006-04-13 |
2007-11-30 |
Astrazeneca Ab |
Nuevos derivados de la tioxantina , composiciones farmacéuticas que los contienen, procedimientos de preparacion y aplicaciones
|
|
ES2487967T3
(es)
|
2006-04-20 |
2014-08-25 |
Pfizer Products Inc. |
Compuestos amido heterocíclicos condensados con fenilo para la prevención y el tratamiento de enfermedades mediadas por la glucoquinasa
|
|
US8771626B2
(en)
|
2006-05-31 |
2014-07-08 |
E I Du Pont De Nemours And Company |
Process for purifying perfluorinated products
|
|
CN101460501A
(zh)
|
2006-06-05 |
2009-06-17 |
阿斯利康(瑞典)有限公司 |
作为髓过氧化物酶抑制剂的吡咯并[3，2-d]嘧啶-4-酮衍生物
|
|
TW200804383A
(en)
|
2006-06-05 |
2008-01-16 |
Astrazeneca Ab |
New compounds
|
|
WO2008023249A1
(en)
|
2006-08-24 |
2008-02-28 |
Chemfit Speciality Chemicals (Pty) Ltd |
Polyvinylchloride composition
|
|
EP2097405A2
(en)
|
2006-11-21 |
2009-09-09 |
Smithkline Beecham Corporation |
Anti-viral compounds
|
|
BRPI0721053A2
(pt)
|
2006-11-29 |
2014-07-29 |
Pfizer Prod Inc |
INIBIDORES DE ESPIROCETONA ACETIL-CoA CARBOXILASE
|
|
US20080153697A1
(en)
|
2006-12-22 |
2008-06-26 |
E. I. Dupont De Nemours And Company |
Mixtures of ammonia and ionic liquids
|
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
TW200918507A
(en)
|
2007-06-29 |
2009-05-01 |
Gilead Sciences Inc |
Novel HIV reverse transcriptase inhibitors
|
|
US8354421B2
(en)
|
2007-06-29 |
2013-01-15 |
Korea Research Insitute Of Chemical Technology |
HIV reverse transcriptase inhibitors
|
|
US20090036425A1
(en)
|
2007-08-02 |
2009-02-05 |
Pfizer Inc |
Substituted bicyclolactam compounds
|
|
JP5043555B2
(ja)
|
2007-08-08 |
2012-10-10 |
株式会社カネカ |
硬化性組成物
|
|
US20090054468A1
(en)
|
2007-08-23 |
2009-02-26 |
Astrazeneca Ab |
New Use 938
|
|
US20090053176A1
(en)
|
2007-08-23 |
2009-02-26 |
Astrazeneca Ab |
New Combination 937
|
|
EP2217588A4
(en)
|
2007-11-02 |
2013-12-04 |
Methylgene Inc |
INHIBITORS OF HISTONE DEACETYLASE
|
|
GB0722680D0
(en)
|
2007-11-19 |
2007-12-27 |
Topotarget As |
Therapeutic compounds and their use
|
|
JP2009167179A
(ja)
|
2007-12-21 |
2009-07-30 |
Daiichi Sankyo Co Ltd |
環状アミン化合物を含有する医薬
|
|
CA2718959A1
(en)
|
2008-03-21 |
2009-09-24 |
Chlorion Pharma, Inc. |
Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
|
|
US8236446B2
(en)
|
2008-03-26 |
2012-08-07 |
Ada Technologies, Inc. |
High performance batteries with carbon nanomaterials and ionic liquids
|
|
CA2722308C
(en)
|
2008-04-15 |
2024-02-27 |
Rfs Pharma, Llc. |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
|
WO2009137508A1
(en)
|
2008-05-05 |
2009-11-12 |
Ada Technologies, Inc. |
High performance carbon nanocomposites for ultracapacitors
|
|
CA2724603A1
(en)
|
2008-05-28 |
2009-12-03 |
Pfizer Inc. |
Pyrazolospiroketone acetyl-coa carboxylase inhibitors
|
|
JP5435592B2
(ja)
|
2008-05-28 |
2014-03-05 |
ファイザー・インク |
ピラゾロスピロケトンアセチルＣｏＡカルボキシラーゼ阻害剤
|
|
JP2011529483A
(ja)
|
2008-07-29 |
2011-12-08 |
ファイザー・インク |
フッ素化ヘテロアリール
|
|
CN102149717B
(zh)
|
2008-08-28 |
2014-05-14 |
辉瑞大药厂 |
二氧杂-双环[3.2.1]辛烷-2，3，4-三醇衍生物
|
|
GB0818063D0
(en)
|
2008-10-02 |
2008-11-05 |
Univ Dundee |
Compounds
|
|
JP5206367B2
(ja)
|
2008-11-27 |
2013-06-12 |
コニカミノルタエムジー株式会社 |
ウレア化合物を含む有機圧電材料
|
|
TW201038580A
(en)
|
2009-02-02 |
2010-11-01 |
Pfizer |
4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives
|
|
US20110319379A1
(en)
|
2009-03-11 |
2011-12-29 |
Corbett Jeffrey W |
Substituted Indazole Amides And Their Use As Glucokinase Activators
|
|
PT2406253E
(pt)
|
2009-03-11 |
2013-09-11 |
Pfizer |
Derivados de benzofuranilo utilizados como inibidores de glucocinase
|
|
WO2010106457A2
(en)
|
2009-03-20 |
2010-09-23 |
Pfizer Inc. |
3-oxa-7-azabicyclo[3.3.1]nonanes
|
|
BRPI1007600A2
(pt)
|
2009-04-23 |
2019-09-24 |
Invasc Therapeutics Inc |
composições e métodos para tratamento de doenças cardiovasculares
|
|
US20100272783A1
(en)
|
2009-04-24 |
2010-10-28 |
Novabay Pharmaceuticals, Inc. |
Methods of Treating Infections of the Nail
|
|
WO2010128414A1
(en)
|
2009-05-08 |
2010-11-11 |
Pfizer Inc. |
Gpr 119 modulators
|
|
EP2427450A1
(en)
|
2009-05-08 |
2012-03-14 |
Pfizer Inc. |
Gpr 119 modulators
|
|
EP2435043A1
(en)
|
2009-05-27 |
2012-04-04 |
Université Libre de Bruxelles |
3-alkyl-5-fluoroindole derivatives as myeloperoxidase inhibitors
|
|
WO2010138901A1
(en)
|
2009-05-29 |
2010-12-02 |
Biogen Idec Ma Inc |
Carboxylic acid-containing compounds, derivatives thereof, and related methods of use
|
|
SG175995A1
(en)
|
2009-06-05 |
2011-12-29 |
Pfizer |
L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
|
|
US8431576B2
(en)
|
2009-06-25 |
2013-04-30 |
Alkermes Pharma Ireland Limited |
Heterocyclic compounds for the treatment of neurological and psychological disorders
|
|
JP5732453B2
(ja)
|
2009-06-25 |
2015-06-10 |
アルカーメス ファーマ アイルランド リミテッド |
Ｎｈ酸性化合物のプロドラッグ
|
|
WO2011003018A2
(en)
|
2009-07-01 |
2011-01-06 |
Cornell University |
Halogenated 2-deoxy-lactones, 2'-deoxy--nucleosides, and derivatives thereof
|
|
WO2011005611A1
(en)
|
2009-07-09 |
2011-01-13 |
Merck Sharp & Dohme Corp. |
Neuromedin u receptor agonists and uses thereof
|
|
DE102009037300A1
(de)
|
2009-08-14 |
2011-02-17 |
Merck Patent Gmbh |
Tetracyanoborate als Schmierstoffe
|
|
US20120263646A1
(en)
|
2009-10-15 |
2012-10-18 |
Guerbet |
Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
|
|
WO2011057220A2
(en)
|
2009-11-09 |
2011-05-12 |
Northwestern University |
Compositions and methods for treating lymphoma
|
|
FR2953145B1
(fr)
|
2009-11-30 |
2013-07-19 |
Inst Francais Du Petrole |
Solution absorbante contenant un inhibiteur de degradation derive de la pyrimidine ou de la triazine et procede d'absorption de composes acides contenus dans un effluent gazeux
|
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
|
US20130085133A1
(en)
|
2010-02-08 |
2013-04-04 |
Sourthern Research Institute Office of Commercialization and Intellectual Prop. |
Anti-viral treatment and assay to screenfor anti-viral agent
|
|
WO2011109799A1
(en)
|
2010-03-05 |
2011-09-09 |
Karyopharm Therapeutics, Inc. |
Nuclear transport modulatiors and uses thereof
|
|
US8592427B2
(en)
|
2010-06-24 |
2013-11-26 |
Alkermes Pharma Ireland Limited |
Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
|
ES2352926B1
(es)
|
2010-12-07 |
2012-01-12 |
Universidad De Granada |
Fenucil deuterado y derivados, procedimiento para su preparación y usos de los mismos.
|
|
WO2013068875A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
2-thiopyrimidinones
|
|
JP6003761B2
(ja)
|
2013-03-27 |
2016-10-05 |
富士ゼロックス株式会社 |
送風管、送風装置及び画像形成装置
|
|
US8884314B1
(en)
|
2013-05-10 |
2014-11-11 |
Osram Sylvania Inc. |
Circuitry configurable based on device orientation
|